Related by context. All words. (Click for frequent words.) 79 Vertex Pharma 78 OSI Pharma 77 Auxilium Pharma 76 Inspire Pharma 75 Regeneron Pharma 74 Cubist Pharma 74 Seattle Genetics SGEN 73 BioMarin Pharma 73 Salix Pharma 72 Isis Pharma 72 Peregrine Pharma 72 Ziopharm 72 Alnylam Pharma 72 Par Pharma 72 SciClone Pharma 71 Immunogen 71 Idenix Pharmaceuticals 71 Optimer Pharma 71 AMAG Pharma 71 Idenix Pharma 71 Synta Pharma 70 ONXX 70 Cyclacel Pharmaceuticals 70 NASDAQ ONXX 69 Somaxon Pharmaceuticals 69 Valeant Pharma 69 Amylin Pharma 69 Inhibitex INHX 68 DepoMed 68 Momenta Pharma 68 Acorda Therapeutics ACOR 68 Curagen 68 Isis Pharmaceuticals ISIS 68 NPS Pharma 68 Adventrx 68 BioMarin Pharmaceutical 68 Onyx Pharmaceuticals 68 OPTR 68 Enzon Pharma 68 AUXL 68 Alexion Pharma 68 DVAX 68 Sunesis Pharmaceuticals 68 Rexahn Pharmaceuticals 68 Onyx Pharmaceuticals Inc 68 Arqule 68 Sunesis Pharma 68 Pharmion PHRM 67 Genentech Roche 67 Endo Pharma 67 Ardea Biosciences 67 Onyx Pharmaceuticals ONXX 67 Xenoport 67 Arena Pharmaceuticals ARNA 67 Ariad Pharma 67 IMGN 67 Regeneron REGN 67 Amylin AMLN 67 Optimer Pharmaceuticals 67 OSI Pharmaceuticals OSIP 67 Nymox Pharmaceutical 67 Vion Pharmaceuticals 67 Keryx Biopharma 67 Vertex VRTX 67 Cell Therapeutics CTIC 67 Auxilium Pharmaceuticals AUXL 67 Xenoport Inc. 67 Eurand NV EURX 67 Omrix Biopharma 66 Endo Pharmaceuticals ENDP 66 Milestone Payment 66 Biogen BIIB 66 Endo Pharmaceuticals NASDAQ ENDP 66 ZymoGenetics ZGEN 66 Allos Therapeutics ALTH 66 Protalix BioTherapeutics 66 Altus Pharmaceuticals 66 TSRX 66 NGSX 66 Nektar Therapeutics NKTR 66 INCY 66 Alkermes ALKS 66 Exelixis EXEL 66 Lorus Therapeutics 66 REGN 66 Progenics Pharmaceuticals 66 Targacept TRGT 66 VIVUS VVUS 66 Savient Pharmaceuticals 66 Affymax AFFY 66 Durect 66 Penwest Pharma 66 BioDelivery Sciences 66 ABII 66 Panitumumab 66 BPAX 66 Threshold Pharma 66 Auxilium Pharmaceuticals 66 Serono SRA 66 Teva Pharma 66 Synta Pharmaceuticals 66 ImClone Erbitux 66 Biogen Elan 66 Immunomedics 66 Lexicon Pharmaceuticals 65 Regeneron Pharmaceuticals REGN 65 Anika Therapeutics 65 Takeda Pharma 65 Intermune 65 Milestone Payments 65 Teva Pharm 65 Celgene Revlimid 65 ISPH 65 Napo Pharmaceuticals 65 Investigational Compound 65 Anadys Pharmaceuticals 65 Febuxostat 65 Rheumatoid Arthritis Drug 65 Somaxon Pharma 65 Noven Pharma 65 Biosante 65 Celgene NASDAQ CELG 65 DOV Pharmaceutical 65 initiate Phase 2a 65 Valeant Pharmaceuticals VRX 65 Aryx Therapeutics 65 Metabasis Therapeutics 65 MLNM 65 Array BioPharma ARRY 65 Incyte INCY 65 RDEA 65 Par Pharmaceutical PRX 65 Vanda Pharma 65 Pluristem Therapeutics 65 Dynavax Technologies 65 Celgene CELG 65 United Therapeutics UTHR 65 Genelabs Technologies 65 Encysive Pharma 65 PDUFA Date 65 Savient Pharmaceuticals SVNT 65 ACADIA Pharmaceuticals 65 Momenta Pharmaceuticals MNTA 65 Viropharma 65 CoTherix 65 Angiotech Pharma 65 NASDAQ REGN 65 Cephalon NASDAQ CEPH 65 Elan Tysabri 65 Rigel Pharmaceuticals 65 Allergan NYSE AGN 65 Bayer Onyx 65 MAP Pharma 65 Eyetech Pharmaceuticals Inc. 65 Praecis 65 DRRX 64 Bristol Myers BMY 64 Halozyme Therapeutics 64 Nexavar sorafenib 64 Progenics Pharma 64 Aflibercept 64 Idera Pharmaceuticals 64 SciClone Pharmaceuticals 64 Ariad Pharmaceuticals 64 Lupus Drug 64 AMAG Pharmaceuticals 64 Biomarin 64 Tezampanel 64 Ligand Pharma 64 ZIOP 64 BioCryst Pharma 64 EPCT 64 Zensana 64 Nasdaq CADX 64 Spectrum Pharmaceuticals SPPI 64 CRTX 64 Anadys Pharma 64 PSDV 64 IDIX 64 Vical VICL 64 PTK ZK 64 Myogen MYOG 64 PDL BioPharma PDLI 64 Progenics Pharmaceuticals PGNX 64 Quick Facts2 64 GTOP 64 Medicis Pharma 64 Earnings Preview Bristol Myers 64 Icagen ICGN 64 Alexion Pharmaceuticals ALXN 64 NASDAQ PGNX 64 Psoriasis Drug 64 Oxigene 64 Boceprevir 64 Roche Avastin 64 Velcade bortezomib 64 Ziopharm Oncology 64 Vicuron Pharmaceuticals 64 CV Therapeutics CVTX 64 ENZN 64 ATHX 64 ONTY 64 ZGEN 64 PharmaVitae Profile 64 Enzon Pharmaceuticals 64 Alnylam ALNY 64 Cephalon CEPH 64 Pegintron 64 Dificid 64 carfilzomib 64 Trubion Pharmaceuticals TRBN 64 VPHM 64 Sepracor SEPR 64 Emisphere Technologies 64 QLTI 64 CRXX 64 ViroPharma VPHM 64 SCRX 64 Marketing Authorisation Application 64 Cypress Bioscience 63 Million Milestone Payment 63 GALNS 63 Drug Fails 63 Zadaxin 63 Peregrine Pharmaceuticals 63 Scolr Pharma 63 Forest Laboratories FRX 63 Carrols Restaurant 63 NBIX 63 Phase III Trials 63 Corcept Therapeutics 63 Alizyme 63 Entecavir 63 Alexza Pharmaceuticals ALXA 63 NDA Submission 63 Meets Primary Endpoint 63 Gilead Sciences GILD 63 Inspire Pharmaceuticals Inc 63 Allovectin 7 63 TTHI 63 SSRX 63 CLDX 63 Roche Actemra 63 Roche RHHBY 63 Forest Labs FRX 63 MGI Pharma 63 Osiris Therapeutics 63 Incyte Corp 63 Æterna Zentaris 63 Oscient Pharmaceuticals 63 Cytokinetics CYTK 63 KV Pharma 63 Avanir 63 Amgen Vectibix 63 Bayer Nexavar 63 Pivotal Phase III 63 CDP# 63 Lung Cancer Drug 63 Pirfenidone 63 BioSante Pharmaceuticals 63 Lowers FY# Outlook 63 Oncothyreon Inc 63 Fanapt iloperidone 63 Hana Biosciences 63 Cadence Pharmaceuticals 63 Backs FY# Forecast 63 Human Genome Sciences HGSI 63 Adolor ADLR 63 BMRN 63 Encysive Pharmaceuticals 63 AEterna Zentaris 63 PDL Biopharma 63 XTL Biopharmaceuticals 63 Phase IIb Trial 63 NASDAQ ISTA 63 THRX 63 Alnara Pharmaceuticals 63 SGEN 63 InterMune ITMN 63 LAF# 63 Depomed DEPO 63 Relistor 63 OGXI 63 TRACON Pharmaceuticals 63 Cladribine 63 Celgene Thalomid 63 NOVN 63 Atherogenics 63 FY# EPS Outlook 63 ALNY 63 Indevus Pharma 63 MOGN 63 Milestone Payment From 63 AMAG Pharmaceuticals AMAG 63 CRXL 63 Lifts FY# Outlook 63 Keryx Biopharmaceuticals 63 AstraZeneca AZN 63 KERX 63 Novartis NVS 63 SCHEDULED TO PREMIERE 63 ocrelizumab 63 Generic Version Of 63 Avanir Pharmaceuticals AVNR 63 Transition Therapeutics 63 WILEX 63 Bayer BAYRY 63 Savient Pharma 63 Loramyc 63 VEGF Trap 63 Patient Enrollment 63 ITAX 63 Aveo Pharmaceuticals 63 Impax Labs 63 Cyclacel Pharma 63 Vertex hepatitis C 63 XNPT 63 Mannkind 63 Auxilium Pharmaceuticals Inc 63 Delcath Systems DCTH 63 Orexigen Therapeutics OREX 63 Acadia Pharmaceuticals ACAD 63 Perrigo PRGO 63 Schering SHR 63 TKPHF 63 Vertex Pharmaceuticals VRTX 63 Arthritis Drug 63 Vicriviroc 63 NASDAQ VRTX 63 Amag 63 Teva Pharmaceutical TEVA 63 Transcept Pharmaceuticals 63 Flamel Technologies FLML 63 midstage trials 63 PHRM 62 SOMX 62 Nexavar ® 62 SUPG 62 NASDAQ AEZS 62 Transkaryotic Therapies TKTX 62 SGXP 62 elotuzumab 62 Gilead GILD 62 Telaprevir 62 Transcept Pharma 62 Migenix 62 Telbivudine 62 ALXA 62 Trubion Pharmaceuticals 62 Completes Patient Enrollment 62 XOMA XOMA 62 Fast Track Status 62 Pazopanib 62 Onyx Pharmaceuticals NASDAQ ONXX 62 ISTA Pharmaceuticals 62 Medivation Inc 62 Acorda Therapeutics Inc 62 Zentaris 62 Generex Biotechnology 62 Salix Pharmaceuticals Ltd 62 Acadia Pharmaceuticals 62 phase IIb trial 62 Neurocrine Biosciences NBIX 62 Nasdaq SLXP 62 Glufosfamide 62 Chelsea Therapeutics 62 ImmuPharma 62 Pfizer Sutent 62 Theravance THRX 62 Generex Biotechnology GNBT 62 MDVN 62 Immunomedics IMMU 62 Immunomedics Inc 62 Arpida 62 Therapeutic Competitors companiesandmarkets.com adEgemonye 62 Backs FY# Outlook 62 Fusilev 62 Gattex 62 POZN 62 Tanezumab 62 Corlux 62 Integra Lifesciences 62 Keryx 62 Allos Therapeutics Incorporated 62 Genzyme Nasdaq GENZ 62 Migraine Drug 62 Mylan Labs MYL 62 Celgene 62 Entremed 62 BLA filing 62 Keryx Biopharmaceuticals KERX 62 AEterna 62 Phase 2b Clinical Trial 62 Micromet MITI 62 Civacir 62 Bristol Myers NYSE BMY 62 Updates FY# EPS 62 Genzyme GENZ 62 Human Genome HGSI 62 AKRX 62 Sigma Aldrich SIAL 62 MEDX 62 Feraheme ® 62 Abbott ABT 62 MannKind MNKD 62 Regeneron Pharmaceuticals Inc 62 Trubion Pharma 62 Akela Pharma 62 ResMed RMD 62 NASDAQ SLXP 62 Cypress Biosciences 62 Allos Therapeutics 62 Begins Dosing 62 Nasdaq HALO 62 Regeneron Pharmaceuticals 62 Dendreon Provenge 62 Amrubicin 62 Voraxaze 62 Nasdaq ACHN 62 Alnylam Nasdaq ALNY 62 Novadel 62 Ambrilia Biopharma 62 Xiaflex 62 Qiagen NV QGEN 62 Achillion Pharmaceuticals Inc 62 AMRN 62 NASDAQ IMGN 62 Biogen Idec Elan 62 Indiplon 62 Vpriv 62 Panzem 62 Antigenics 62 NASDAQ SGEN 62 SangStat 62 VRUS 62 Nicox 62 HuMax CD4 62 generic Allegra 62 Array BioPharma 62 Clinical Trial Results 62 Arcalyst 62 Oncogenex 62 Dainippon Sumitomo 62 VRTX 62 DepoMed Inc. 62 SPRYCEL ® 62 EYET 62 Barr Pharmaceuticals BRL 62 Poniard Pharmaceuticals 62 Achieves Primary Endpoint 62 Rigel Pharmaceuticals RIGL 62 Sciele Pharma 62 Ixempra 62 FDA Approvable Letter 62 Incyte 62 NASDAQ KERX 62 QCOR 62 Xoma 62 InNexus Biotechnology 62 Stavzor 62 Phase III Clinical Trials 61 Neurosearch 61 Mylan Labs 61 Protalix BioTherapeutics PLX 61 Phase III Trial 61 NASDAQ ANDS 61 BioSante Pharmaceuticals NASDAQ BPAX 61 Submits NDA 61 Medarex MEDX 61 Nippon Kayaku 61 refractory acute lymphoblastic 61 Nasdaq OPTR 61 Hologic HOLX 61 PDL BioPharma 61 Atelvia 61 Cell Therapeutics Inc 61 NASDAQ INCY 61 PF # [002] 61 LXRX 61 Medivation MDVN 61 Acorda Therapeutics NASDAQ ACOR 61 Shire Plc SHPGY 61 Lupuzor 61 OPXA 61 NPS Pharmaceuticals NPSP 61 Biomarin Pharm 61 IMMU 61 DYAX 61 Ono Pharmaceutical 61 AMLN 61 IND Filing 61 Pharmasset VRUS 61 Cell Genesys CEGE 61 GENR 61 NASDAQ NVAX 61 Synta Pharmaceuticals SNTA 61 Impax Laboratories Inc 61 Novartis VIRT X 61 NPS Pharmaceuticals 61 Questcor Pharmaceuticals QCOR 61 Kos Pharma 61 ThermoDox R 61 ALTH 61 midstage clinical 61 experimental hepatitis C 61 GlaxoSmithKline plc GSK 61 Initiates Clinical 61 SHP.L 61 CRME 61 Tesmilifene 61 Roche OTC RHHBY 61 NASDAQ OPTR 61 ACHN 61 Phase 1b Clinical Trial 61 RGEN 61 Somatuline Autogel 61 OMRIX Biopharmaceuticals 61 Archexin 61 Dyax DYAX 61 SUTENT ® 61 AVNR 61 NSTK 61 Poniard Pharmaceuticals PARD 61 FOLOTYN ® 61 Amylin Pharmaceuticals AMLN 61 Mindray Medical 61 Canvaxin 61 Momenta Pharmaceuticals 61 BioMarin BMRN 61 Vertex Pharmaceuticals NASDAQ VRTX 61 RNVS 61 NASDAQ CLDX 61 Penwest Pharmaceuticals Co 61 AGI Therapeutics 61 JAK inhibitor 61 VNDA 61 Idenix Pharmaceuticals Inc 61 Phase 2b Trial 61 Idenix Pharmaceuticals Inc. 61 PCRX 61 blood thinner prasugrel 61 CYTR 61 LGND 61 NASDAQ PCYC 61 Romiplostim 61 Carfilzomib 61 Questcor Pharmaceuticals 61 Ltd Therapeutic Competitors 61 Amgen Prolia 61 Biodel BIOD 61 Edwards Lifesciences EW 61 Annamycin 61 Addex Pharmaceuticals 61 Announcement acc 61 Therapeutic Competitors 61 Alvesco 61 Apricus Biosciences 61 Phase III Clinical Trial 61 ENCY 61 Santhera 61 Cardiome Pharma 61 Nuvion 61 Biovail BVF 61 Zalbin 61 Reverset 61 Threshold Pharmaceuticals 61 Shire SHPGY 61 Schering Plough SGP 61 CLDA 61 Dendreon DNDN 61 NYSE Amex PTN 61 NASDAQ NPSP 61 ARYX 61 axitinib 61 CIP TRAMADOL ER 61 Inc Therapeutic Competitors 61 NASDAQ ALTH 61 Akorn Inc 61 Daclizumab 61 RPRX 61 antibiotic Cubicin 61 Momenta Pharmaceuticals Inc 61 Sanvar 61 Immunomedics Inc. 61 PXSL 61 Oglemilast 61 NASDAQ CYTX 61 Heplisav 61 TTNP 61 GILD GILD 61 Generic Lovenox 61 IDM Pharma 61 FDA Accepts 61 CAMPATH 61 TolerRx 61 Avanir Pharma 61 BTRX 61 SEPR 61 Initiate Phase 61 Zyflo 61 Coley Pharmaceutical 61 Folotyn 61 Adeona Pharmaceuticals 61 Zeltia 61 Warner Chilcott WCRX 61 SCLN 61 Ambrisentan 61 KV.A 61 Fampridine 61 Alpharma ALO 61 mertansine 61 phase IIb 61 Nasdaq CBST 61 Trimeris Nasdaq TRMS 61 Novavax NVAX 61 Pharmos Corporation 61 Rigel Pharmaceuticals Inc. 61 Kyowa Hakko Kirin 61 Transkaryotic 61 Aegerion 61 JAK Inhibitor 61 RAPTIVA r 61 Targanta Therapeutics 61 Salix Pharmaceuticals NASDAQ SLXP 61 Receives Approvable Letter 61 Phenoptin 61 TRBN 60 Firdapse 60 AZN.L 60 Nasdaq VRTX today 60 Shire SHP.L 60 Lev Pharmaceuticals 60 Pivotal Phase 60 Sanctura XR 60 Psivida 60 MiddleBrook Pharmaceuticals 60 Momenta Pharma MNTA 60 Nps Pharmaceuticals Incorporated 60 Levadex 60 Sirona Dental 60 Altana AAA 60 Accuray ARAY 60 Schwarz Pharma 60 pradefovir 60 Ridaforolimus 60 MBRX 60 Protein Design 60 Cornerstone Therapeutics 60 CVTX 60 Welichem 60 Combination REOLYSIN R 60 SHPGY 60 Novelos Therapeutics 60 Taiho Pharmaceutical 60 Phase 2a Trial 60 Avanir Pharmaceuticals 60 GlaxoSmithKline Tykerb 60 Paladin Labs 60 Lilly Cymbalta 60 Targanta 60 GW Pharma 60 Inhaled Insulin 60 Cerus CERS 60 XTL Biopharmaceuticals Ltd. 60 AnGes MG 60 Optimer Pharmaceuticals OPTR 60 Colazal 60 NASDAQ IDIX 60 Jerini 60 PREOS R 60 Loss Shrinks 60 Genelabs Technologies Inc. 60 Bicifadine 60 Cholesterol Drug 60 Maribavir 60 Summary Genmab 60 NOVAVAX 60 Rezonic 60 Cetrorelix 60 Vertex Pharmaceuticals Inc 60 Nasdaq RDEA 60 Qiagen QGEN 60 Palatin Technologies 60 Threshold Pharmaceuticals Inc. 60 Biogen Idec Nasdaq BIIB 60 Nasdaq IMGN 60 Immunogen IMGN 60 Cepheid CPHD 60 Sunesis Pharmaceuticals Inc. 60 Preos 60 ASA# 60 MNTA 60 Genentech Herceptin 60 ABGX 60 Akhtar Samad 60 Harbor BioSciences 60 XenoPort NASDAQ XNPT 60 SAR# [004] 60 GSK '# 60 virus HCV protease inhibitor 60 Brush Engineered 60 Satraplatin 60 Eli Lilly LLY 60 Progenics Pharmaceuticals Inc 60 Alkermes NASDAQ ALKS 60 Cethromycin 60 MDCO 60 Voltaren Gel 60 Toyama Chemical 60 Treanda 60 Pharmasset 60 Drug Maker 60 Ventavis 60 IVGN 60 Drugmaker 60 Sunovion 60 initiate Phase IIb 60 Ocrelizumab 60 Laquinimod 60 Sanofi NYSE SNY 60 Impax Laboratories IPXL 60 ImmunoGen Inc. 60 Alexza Pharma 60 Generic Version 60 Vernakalant 60 PDGI 60 Dendreon Corp 60 Illumigen Biosciences 60 oral ridaforolimus 60 Urigen NA Inc. 60 Valeant Pharmaceuticals NYSE VRX 60 NASDAQ ARIA 60 Zenpep 60 Iloperidone 60 Receive Milestone Payment 60 Teva TEVA 60 rhThrombin 60 Nuvelo NUVO 60 eResearchTechnology 60 cinacalcet HCl 60 Ardea Biosciences Inc. 60 Cytec Industries CYT 60 Promacta 60 MGI Pharma MOGN 60 Enzon Pharmaceuticals Inc 60 Nasdaq INCY 60 Alvine Pharmaceuticals 60 Encysive 60 Nasdaq KERX 60 Tyzeka 60 NASDAQ WCRX 60 Muraglitazar 60 Vanda Pharmaceuticals VNDA 60 Shire plc SHPGY 60 Sinobiopharma 60 Aeterna Zentaris 60 Flutiform ™ 60 Sciele Pharma Inc. 60 HuMax CD# 60 Pivotal Study 60 Plicera 60 Cell Therapeutics 60 Solasia 60 MYGN 60 SCHWARZ PHARMA 60 Titan Pharmaceuticals 60 Santarus SNTS 60 SGX Pharmaceuticals 60 Neurobiological Technologies 60 Medicis Pharmaceutical Corp 60 Bristol Myers Squibb BMY 60 Golimumab 60 AEGR 60 VICL 60 Akorn AKRX 60 Ziopharm Oncology Inc. 60 OSIP 60 ViroPharma Nasdaq VPHM 60 NASDAQ ACOR 60 Abbott Humira 60 Asenapine 60 NASDAQ FLML 60 Eurand NV 60 Amevive 60 Penwest Pharmaceuticals 60 Medigene 60 Glenmark Pharma 60 FlutiformTM 60 Immunotherapeutic 60 Brentuximab Vedotin SGN 60 Sensipar 60 Oncolytics Biotech 60 ViroChem Pharma Inc. 60 Teva Pharmaceuticals TEVA 60 TSPT 60 Genentech Roche Chugai 60 Lucentis ranibizumab 60 Volterra Semi 60 SGMO 60 Cubicin 60 Cypress Bioscience CYPB 60 Tocosol Paclitaxel 60 Osteoporosis Drug 60 NASDAQ DEPO 60 SciClone Pharmaceuticals Inc. 60 Repros Therapeutics RPRX 60 CBRX 60 LymphoStat B TM 60 Kissei Pharmaceutical 60 IPXL 60 OSI Pharmaceutical 60 Initiates Phase III 60 Nasdaq VRTX 60 Kynapid 60 Firazyr 60 Vivus VVUS 60 AEterna Zentaris Inc. 59 GlaxoSmithKline Imitrex 59 SLXP 59 Trubion Pharmaceuticals Inc. 59 Myriad Genetics Inc 59 HEPH 59 CPRX 59 Combigan 59 BARACLUDE R 59 NASDAQ BMRN 59 SVNT 59 ARQL 59 Elan Biogen 59 AstraZeneca Iressa 59 XenoPort XNPT 59 CHF#M 59 Gralise 59 Phase Ib II 59 Pfizer Lyrica 59 initiated Phase Ib 59 Glatiramer Acetate 59 Tyvaso 59 Peg Intron 59 Revises FY# EPS 59 Nasdaq PARD 59 Inex Pharmaceuticals 59 prodrug stimulant 59 UCB Cimzia 59 Dynavax Technologies Corp. 59 Newsflow 59 non nucleoside inhibitor 59 NASDAQ CGEN 59 SNTS 59 SNT MC# 59 Thermo Fisher Scientific TMO 59 Anadys Pharmaceuticals ANDS 59 Biogen Idec BIIB 59 Generic Protonix 59 Pharmion Corporation 59 Sanvar R 59 Pafuramidine 59 NRMX 59 Eyetech Pharmaceuticals 59 NASDAQ PARD 59 STELARA TM 59 ONYX Pharmaceuticals 59 Phase IIIb clinical 59 Zactima 59 Idenix Pharmaceuticals IDIX 59 NASDAQ OGXI 59 Protalix 59 NASDAQ BIIB 59 Nasdaq ONXX 59 Syneron Medical 59 NASDAQ ACHN 59 Cimzia 59 THALOMID R 59 danoprevir 59 pegylated interferons 59 Bifeprunox 59 Nasdaq IMMU 59 Cleveland BioLabs 59 Alexion Pharmaceuticals Inc 59 Vertex Pharmaceuticals Nasdaq VRTX 59 Somatuline Depot 59 NASDAQ MNKD 59 Nasdaq NBIX 59 Javelin Pharmaceuticals 59 NVA# 59 Winemaker Constellation Brands 59 Ltd. CHTP 59 AMEX PLX 59 Ophthotech 59 Merck KGaA Erbitux 59 Partnering Guide 59 Aegerion Pharmaceuticals Inc. 59 Amylin Pharmaceuticals Inc 59 NASDAQ RGEN 59 CAMBRIDGE Mass. Biogen Idec 59 Medicis Pharmaceutical MRX 59 NASDAQ ARRY 59 Revlimid 59 Inc. NASDAQ ITMN 59 RECOTHROM R 59 Novartis 59 Orazol 59 DPP4 inhibitor 59 CoTherix Inc. 59 Successfully Completes Phase 59 Mylan Receives Approval 59 Liraglutide 59 Inc. NASDAQ SGEN 59 Fabry Disease 59 Prolor Biotech 59 NASDAQ NABI 59 Erbitux cetuximab 59 Durect Corporation 59 Krystexxa 59 Cerimon 59 Onyx Pharmaceuticals Inc. 59 NLTX 59 Partnering Agreements 59 USD #.#bln [001] 59 Xinlay 59 BRIM3 59 Accentia Biopharmaceuticals 59 Skyepharma 59 Viramidine 59 Alphatec Holdings 59 BIIB BIIB 59 Troxatyl 59 Rockwood Holdings ROC 59 Uplyso 59 Mycamine 59 NASDAQ IMMU 59 Bemis BMS 59 Cyclacel Pharmaceuticals Inc. 59 RhuDex 59 Receives Orphan Drug Designation 59 Ramoplanin 59 Reaffirms FY# EPS 59 AMAG Pharmaceuticals Inc. 59 Fesoterodine 59 Axcan Pharma 59 Shire Pharmaceuticals SHPGY 59 AMEX ANX 59 Questcor Pharma 59 Progenics 59 ZymoGenetics 59 Eyetech 59 Biodel Inc 59 Cleveland Biolabs 59 dirucotide 59 ImmunoGen IMGN 59 Earnings Preview EBay 59 Phase IIa trials 59 Biogen NASDAQ BIIB 59 Align Technology ALGN 59 Dainippon 59 Milnacipran 59 NASDAQ AVNR 59 Nasdaq KOSN 59 Flutiform 59 Onsolis 59 NASDAQ OREX 59 compound INCB# 59 Nasdaq ACAD 59 Fodosine 59 Provides FY# EPS 59 GENZ 59 Ventrus Biosciences 59 Outlook Disappoints 59 Dasatinib 59 ALIM 59 Asentar 59 Idenix 59 Dynogen 59 Onconase 59 Ariad Pharmaceuticals ARIA 59 NVMI 59 Novartis NYSE NVS 59 NASDAQ ALNY 59 Lavipharm 59 Agenerase 59 Evoltra 59 Exelixis Nasdaq EXEL 59 Biogen IDEC 59 Maintains FY# 59 anidulafungin 59 Humira adalimumab 59 terlipressin 59 Tranzyme 59 NASDAQ SHPGY 59 HELSINN 59 Molecular Insight 59 Nasdaq IDIX 59 Xenazine ® 59 Barrier Therapeutics Inc. 59 Egrifta 59 ITMN 59 Horizant 59 Icatibant 59 MyVax